DENNER ALEXANDER J

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 60% 68% 82%
Transactions
30 77% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -41%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
DENNER ALEXANDER J's trades of Ironwood Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-17 2026-03-17
S Sale
24,127 -14.4%
47.68
US$1,124,881 		24,127 -14.4% 47.68 US$1,124,881
2026-03-17 2026-03-17
S Sale
659 +34.6%
313.28
US$4,219,310 		659 +34.6% 313.28 US$4,219,310
2025-03-06 2025-03-06
US Innoviva Inc (INVA)
S Sale
95,779 +1.3%
496.87
US$4,252,001 		95,779 +1.3% 496.87 US$4,252,001
2025-03-06 2025-03-05
US Innoviva Inc (INVA)
S Sale
270,374 -3.8%
17.63
US$4,766,126 		270,374 -3.8% 17.63 US$4,766,126
2025-03-06 2025-03-04
US Innoviva Inc (INVA)
S Sale
151,175 -2.1%
17.63
US$2,665,079 		151,175 -2.1% 17.63 US$2,665,079
2023-06-20 2023-06-15
US Innoviva Inc (INVA)
B Purchase
62,000 +0.9%
13.13
US$814,196 		62,000 +0.9% 13.13 US$814,196
2023-06-07 2023-06-06
US Innoviva Inc (INVA)
B Purchase
8,000 +0.1%
13.05
US$104,384 		8,000 +0.1% 13.05 US$104,384
2023-06-07 2023-06-05
US Innoviva Inc (INVA)
B Purchase
7,000 +0.1%
13.04
US$91,297 		7,000 +0.1% 13.04 US$91,297
2023-05-30 2023-05-30
US Innoviva Inc (INVA)
B Purchase
120,000 +1.7%
13.01
US$1,560,648 		120,000 +1.7% 13.01 US$1,560,648
2023-05-30 2023-05-26
US Innoviva Inc (INVA)
B Purchase
30,000 +0.4%
13.12
US$393,729 		30,000 +0.4% 13.12 US$393,729
2023-05-30 2023-05-25
US Innoviva Inc (INVA)
B Purchase
50,000 +0.7%
13.09
US$654,330 		50,000 +0.7% 13.09 US$654,330
2023-05-19 2023-05-18
US Innoviva Inc (INVA)
B Purchase
10,000 +0.1%
13.05
US$130,538 		10,000 +0.1% 13.05 US$130,538
2023-05-19 2023-05-17
US Innoviva Inc (INVA)
B Purchase
50,000 +0.7%
13.07
US$653,690 		50,000 +0.7% 13.07 US$653,690
2023-05-15 2023-05-11
US Innoviva Inc (INVA)
B Purchase
290,000 +4.4%
12.34
US$3,577,411 		290,000 +4.4% 12.34 US$3,577,411
2021-03-10 2021-03-10
B Purchase
75,000 +0.5%
10.54
US$790,500 		75,000 +0.5% 10.54 US$790,500
2021-03-10 2021-03-08
B Purchase
150,000 +0.9%
10.30
US$1,545,000 		150,000 +0.9% 10.30 US$1,545,000
2021-03-05 2021-03-05
B Purchase
175,000 +1.1%
10.01
US$1,751,750 		175,000 +1.1% 10.01 US$1,751,750
2021-03-05 2021-03-04
B Purchase
250,000 +1.6%
10.00
US$2,500,000 		250,000 +1.6% 10.00 US$2,500,000
2021-03-05 2021-03-03
B Purchase
350,000 +2.3%
10.02
US$3,507,000 		350,000 +2.3% 10.02 US$3,507,000
2021-03-02 2021-03-02
B Purchase
500,000 +3.4%
9.56
US$4,780,000 		500,000 +3.4% 9.56 US$4,780,000
2021-03-02 2021-03-01
B Purchase
344,900 +2.4%
9.60
US$3,311,040 		344,900 +2.4% 9.60 US$3,311,040
2021-03-02 2021-02-26
B Purchase
505,100 +3.6%
9.20
US$4,646,920 		505,100 +3.6% 9.20 US$4,646,920
2021-02-12 2021-02-12
S Sale
10,619,949 -100.0%
2.27
US$24,107,284 		10,619,949 -100.0% 2.27 US$24,107,284
2021-02-12 2021-02-11
S Sale
10,000,000 -48.5%
2.59
US$25,900,000 		10,000,000 -48.5% 2.59 US$25,900,000
2019-06-28 2019-06-28
US Medicines Co (MDCO)
B Purchase
50,000 +1.2%
33.00
US$1,650,000 		50,000 +1.2% 33.00 US$1,650,000
2019-05-31 2019-05-30
US Medicines Co (MDCO)
B Purchase
50,000 +1.2%
34.81
US$1,740,500 		50,000 +1.2% 34.81 US$1,740,500
2019-05-31 2019-05-29
US Medicines Co (MDCO)
B Purchase
35,000 +0.9%
34.85
US$1,219,750 		35,000 +0.9% 34.85 US$1,219,750
2019-05-22 2019-05-22
US Medicines Co (MDCO)
B Purchase
139,000 +3.5%
33.13
US$4,605,070 		139,000 +3.5% 33.13 US$4,605,070
2019-05-22 2019-05-21
US Medicines Co (MDCO)
B Purchase
132,000 +3.5%
33.95
US$4,481,400 		132,000 +3.5% 33.95 US$4,481,400
2019-05-22 2019-05-20
US Medicines Co (MDCO)
B Purchase
160,000 +4.4%
34.50
US$5,520,000 		160,000 +4.4% 34.50 US$5,520,000
2019-05-02 2019-05-02
US Biogen Inc (BIIB)
B Purchase
38,000 +6.3%
231.24
US$8,787,120 		38,000 +6.3% 231.24 US$8,787,120
2019-05-02 2019-05-01
US Biogen Inc (BIIB)
B Purchase
30,000 +5.2%
229.46
US$6,883,800 		30,000 +5.2% 229.46 US$6,883,800
2019-05-02 2019-04-30
US Biogen Inc (BIIB)
B Purchase
50,342 +9.6%
229.25
US$11,540,904 		50,342 +9.6% 229.25 US$11,540,904
2019-03-08 2019-03-06
US Medicines Co (MDCO)
B Purchase
248,100 +7.3%
24.91
US$6,180,171 		248,100 +7.3% 24.91 US$6,180,171
2019-03-05 2019-03-05
US Medicines Co (MDCO)
B Purchase
181,900 +5.7%
26.07
US$4,742,133 		181,900 +5.7% 26.07 US$4,742,133
2019-03-05 2019-03-04
US Medicines Co (MDCO)
B Purchase
325,000 +11.3%
25.45
US$8,271,250 		325,000 +11.3% 25.45 US$8,271,250
2019-03-05 2019-03-01
US Medicines Co (MDCO)
B Purchase
100,000 +3.6%
25.15
US$2,515,000 		100,000 +3.6% 25.15 US$2,515,000
2019-02-01 2019-02-01
US Biogen Inc (BIIB)
B Purchase
7,000 +1.4%
328.45
US$2,299,163 		7,000 +1.4% 328.45 US$2,299,163
2019-02-01 2019-01-31
US Biogen Inc (BIIB)
B Purchase
25,800 +5.2%
330.52
US$8,527,393 		25,800 +5.2% 330.52 US$8,527,393
2019-02-01 2019-01-30
US Biogen Inc (BIIB)
B Purchase
30,000 +6.5%
324.86
US$9,745,851 		30,000 +6.5% 324.86 US$9,745,851